Precursor compounds for providing retinoids of the vitamin a5 pathway and uses thereof

Patent number:

WO2018091937

No items found.

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13,14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Countries:

Spain

Regions:

Galicia

Centers:

UNIVERSIDAD DE VIGO, DE STRASBOURG UNIV

Other entities:

University of Debrecen; Universite de Strasbourg; Debreceni Egyetem

Sectors:

Health

Subsectors:

Biotechnology

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13, 14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Comments

Other related patents

Health

NANOCONJUGATES FORMED FROM DENDRITIC MOLECULES AND PEPTIDES AS ANTITUMOUR AGENTS AGAINST CANCER

Countries

Spain

Health

METHOD FOR MONITORING ANTIPSYCHOTIC TREATMENT

Countries

Spain

Health

SARS-CoV-2 peptides and proteins with reduced adherence to Angiotensin Converting Enzyme-2

Countries

Spain

Get back to patents directory